KR960701068A - 실릴화 아세틸콜린에스테라제 억제제(Silylated acetylcholinesterase inhibitors) - Google Patents
실릴화 아세틸콜린에스테라제 억제제(Silylated acetylcholinesterase inhibitors) Download PDFInfo
- Publication number
- KR960701068A KR960701068A KR1019950703485A KR19950703485A KR960701068A KR 960701068 A KR960701068 A KR 960701068A KR 1019950703485 A KR1019950703485 A KR 1019950703485A KR 19950703485 A KR19950703485 A KR 19950703485A KR 960701068 A KR960701068 A KR 960701068A
- Authority
- KR
- South Korea
- Prior art keywords
- alkyl
- compound
- trifluoro
- trimethylsilyl
- fluoro
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic System
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic System
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/0803—Compounds with Si-C or Si-Si linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
콜린에스테라제 억제 활성을 갖는 불화된 실릴화 방향족 화합물 및 이러한 화합물을 사용하여 퇴행성 치매증을 치료하는 방법.
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (10)
- 일반신(Ⅰ)의 화합물, 이의 입체이성체 또는 혼합물 및 약제학적으로 허용가능한 이의 염.상기식에서, Z 및 Z′는 각각 독립적으로 H 또는 F이며, 단 Z 및 Z′중의 하나 이상은 F이고; Q는 또는이며; X는 H, Br, Cl, F 또는 CF3이고; Y는 H, OH, (C1-6)알킬, -(CH2)mORs, 하이드록시(C1-6)알킬, -(CH2)nNR6R6′, 아지도, CN, CO2R4, COR6, SO3H, Br, Cl, F, NO2또는 -(CH2)n′Si R1′R2′R3′이며, 단 Z와 Z′가 모두 F인 경우, Y는 H 또는 F이고; R1, R2, R3, R1′, R2′및 R3′는 각각 독립적으로 (C1-10)알킬 또는 (CH2)n″아릴이고; R4는 H, (C1-10)알킬, 페닐, 벤질 또는 펜에틸이며; R5는 H, (C1-10)알킬, 벤질 또는 펜에틸이며; R6및 R6′는 수소 또는 (C1-10)알킬이며; m은 0 내지 4의 정수이고; n, n′및 n″는 각각 독립적으로 0 내지 2의 정수이다.
- 제1항에 있어서, R1, R2, R3, R1′, R2′및 R3′가 존재하는 경우, 각각 독립적으로 메틸인 화합물.
- 제1항에 있어서, Z가 F인 화합물.
- 제1항에 있어서, Z′가 H인 화합물.
- 제1항에 있어서, Q가 C(O) 또는 CH(OH)인 화합물.
- 제1항에 있어서, 2,2,2-트리플루오로-1-(3-트리메틸실릴-6-플루오로)페닐 에탄온; 2,2,2-트리플루오로-1-(3-트리메틸실릴-6-플루오로)페닐 에탄올; 2,2,2-트리플루오로-1-(2-플루오로-5-디메틸에틸실릴)페닐 에탄온; 2,2,2-트리플루오로-1-(2-플루오로-3-트리메틸실릴)페닐 에탄온; 2,2,2-트리플루오로-1-(2,6-디플루오로-3-트리메틸실릴)페닐 에탄온; 2,2,2-트리플루오로-1-(2-플루오로-3-하이드록시메틸-5-트리메틸실릴)페닐 에탄온; 2,2,2-트리플루오르-1-(2-플루오로-3-n-부틸-5-트리메틸실릴)페닐 에탄온; 또는 2,2,2-트리플루오로-1-(2-플루오로-3-아미노-5-트리메틸실릴)페닐 에탄온 하이드로 클로라이드인 화합물.
- 약제학적 활성 화합물로서 사용하기 위한, 제1항에 따르는 화합물.
- 퇴행성 치매증의 치료에 사용하기 위한, 제1항에 따르는 화합물.
- 퇴행성 치매증 치료용 약제학적 조성물을 제조하기 위한, 임의로 약제학적으로 허용가능한 담체와 혼합된 상태로 존재하는, 제1항에 따르는 화합물의 용도.
- 일반식의 4-플루오로트리알킬실리페닐 화합물을 리튬염으로 전환시키고, 반응물을 일반식 XCF2CO2R의 에스테르〔여기서, X는 할라이드이고 R은 (C1-6)알킬이다〕또는 일반식 XCF2CO2Li의 산 리튬염과 배합시킨 후, 가수분해시켜 일반식의 케톤(여기서, X′는 H, Br, Cl 또는 F이다)을 수득하고, 이어서 케톤을 아실 클로라이드(ClCOR4)에 의해 에스테르화될 수 있는 알콜로 가수분해시킴으로써, 일반식(Ⅰ)의 화합물, 이의 입체이성체 또는 혼합물 및 약제학적으로 허용가능한 이의 염을 제조하는 방법.(Ⅰ)상기식에서, Q는또는이며; X′는 H, Br, Cl 또는 F이고; R1, R2및 R3은 각각 독립적으로 C1-10알킬 또는 (CH2)n″아릴이고; R4는 H, (C1-10)알킬, 페닐, 벤질 또는 펜에틸이며, m은 0 내지 4의 정수이고; n″는 0 내지 2의 정수이다.*참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP93400385A EP0611769A1 (en) | 1993-02-16 | 1993-02-16 | Silylated acetylcholinesterase inhibitors |
EP93400385.6 | 1993-02-16 | ||
PCT/US1994/000720 WO1994019356A1 (en) | 1993-02-16 | 1994-01-25 | Silylated acetylcholinesterase inhibitors |
Publications (2)
Publication Number | Publication Date |
---|---|
KR960701068A true KR960701068A (ko) | 1996-02-24 |
KR100336547B1 KR100336547B1 (ko) | 2002-11-02 |
Family
ID=8214682
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019950703485A KR100336547B1 (ko) | 1993-02-16 | 1994-01-25 | 실릴화아세틸콜린에스테라제억제제 |
Country Status (19)
Country | Link |
---|---|
EP (2) | EP0611769A1 (ko) |
JP (1) | JP3516955B2 (ko) |
KR (1) | KR100336547B1 (ko) |
CN (1) | CN1043575C (ko) |
AT (1) | ATE152725T1 (ko) |
AU (1) | AU672885B2 (ko) |
CA (1) | CA2154870C (ko) |
DE (1) | DE69403068T2 (ko) |
DK (1) | DK0684951T3 (ko) |
ES (1) | ES2104358T3 (ko) |
FI (1) | FI111461B (ko) |
GR (1) | GR3024151T3 (ko) |
HU (1) | HUT72736A (ko) |
IL (1) | IL108623A0 (ko) |
MX (1) | MX9401175A (ko) |
NO (1) | NO305517B1 (ko) |
NZ (1) | NZ262247A (ko) |
WO (1) | WO1994019356A1 (ko) |
ZA (1) | ZA94925B (ko) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0627400A1 (en) * | 1993-06-04 | 1994-12-07 | Merrell Dow Pharmaceuticals Inc. | Aromatic acetylcholinesterase inhibitors |
CN100431539C (zh) * | 2004-01-12 | 2008-11-12 | 和泓生物技术(上海)有限公司 | 乙酰胆碱酯酶抑制剂在制备治疗帕金森病药物中的应用 |
WO2008055945A1 (en) | 2006-11-09 | 2008-05-15 | Probiodrug Ag | 3-hydr0xy-1,5-dihydr0-pyrr0l-2-one derivatives as inhibitors of glutaminyl cyclase for the treatment of ulcer, cancer and other diseases |
WO2008065141A1 (en) | 2006-11-30 | 2008-06-05 | Probiodrug Ag | Novel inhibitors of glutaminyl cyclase |
ZA200905537B (en) | 2007-03-01 | 2010-10-27 | Probiodrug Ag | New use of glutaminyl cyclase inhibitors |
JP5667440B2 (ja) | 2007-04-18 | 2015-02-12 | プロビオドルグ エージー | グルタミニルシクラーゼ阻害剤としてのチオ尿素誘導体 |
MX2012002993A (es) | 2009-09-11 | 2012-04-19 | Probiodrug Ag | Derivados heterociclicos como inhibidores de ciclasa glutaminilo. |
CA2789014C (en) | 2010-02-09 | 2019-01-15 | Michela Gallagher | Methods and compositions for improving cognitive function |
JP6026284B2 (ja) | 2010-03-03 | 2016-11-16 | プロビオドルグ エージー | グルタミニルシクラーゼの阻害剤 |
MX2012010470A (es) | 2010-03-10 | 2012-10-09 | Probiodrug Ag | Inhibidores heterociclicos d ciclasa de glutaminilo (qc, ec .3 2. 5). |
US8541596B2 (en) | 2010-04-21 | 2013-09-24 | Probiodrug Ag | Inhibitors |
WO2012123563A1 (en) | 2011-03-16 | 2012-09-20 | Probiodrug Ag | Benz imidazole derivatives as inhibitors of glutaminyl cyclase |
JP6440625B2 (ja) | 2012-11-14 | 2018-12-19 | ザ・ジョンズ・ホプキンス・ユニバーシティー | 精神分裂病を処置するための方法および組成物 |
CA2904767C (en) | 2013-03-15 | 2022-06-21 | Agenebio, Inc. | Methods and compositions for improving cognitive function |
WO2014144663A1 (en) | 2013-03-15 | 2014-09-18 | The Johns Hopkins University | Methods and compositions for improving cognitive function |
WO2016191288A1 (en) | 2015-05-22 | 2016-12-01 | Agenebio, Inc. | Extended release pharmaceutical compositions of levetiracetam |
EP3461819B1 (en) | 2017-09-29 | 2020-05-27 | Probiodrug AG | Inhibitors of glutaminyl cyclase |
CN112047973B (zh) * | 2019-06-06 | 2022-11-18 | 上海科技大学 | 一种大麻素类化合物,其制备方法、组合物和用途 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0403713A1 (en) * | 1989-06-22 | 1990-12-27 | Merrell Dow Pharmaceuticals Inc. | Novel acetylcholinesterase inhibitors |
-
1993
- 1993-02-16 EP EP93400385A patent/EP0611769A1/en not_active Withdrawn
-
1994
- 1994-01-25 AT AT94908615T patent/ATE152725T1/de active
- 1994-01-25 NZ NZ262247A patent/NZ262247A/en unknown
- 1994-01-25 EP EP94908615A patent/EP0684951B1/en not_active Expired - Lifetime
- 1994-01-25 CN CN94191196A patent/CN1043575C/zh not_active Expired - Fee Related
- 1994-01-25 AU AU61641/94A patent/AU672885B2/en not_active Ceased
- 1994-01-25 DK DK94908615.1T patent/DK0684951T3/da active
- 1994-01-25 HU HU9502406A patent/HUT72736A/hu unknown
- 1994-01-25 KR KR1019950703485A patent/KR100336547B1/ko not_active IP Right Cessation
- 1994-01-25 CA CA002154870A patent/CA2154870C/en not_active Expired - Fee Related
- 1994-01-25 JP JP51897494A patent/JP3516955B2/ja not_active Expired - Fee Related
- 1994-01-25 DE DE69403068T patent/DE69403068T2/de not_active Expired - Lifetime
- 1994-01-25 ES ES94908615T patent/ES2104358T3/es not_active Expired - Lifetime
- 1994-01-25 WO PCT/US1994/000720 patent/WO1994019356A1/en active IP Right Grant
- 1994-02-10 ZA ZA94925A patent/ZA94925B/xx unknown
- 1994-02-11 IL IL10862394A patent/IL108623A0/xx unknown
- 1994-02-15 MX MX9401175A patent/MX9401175A/es not_active Application Discontinuation
-
1995
- 1995-08-15 FI FI953851A patent/FI111461B/fi not_active IP Right Cessation
- 1995-08-15 NO NO953201A patent/NO305517B1/no unknown
-
1997
- 1997-07-16 GR GR970401801T patent/GR3024151T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
AU6164194A (en) | 1994-09-14 |
MX9401175A (es) | 1994-08-31 |
CN1117733A (zh) | 1996-02-28 |
ATE152725T1 (de) | 1997-05-15 |
IL108623A0 (en) | 1994-05-30 |
NO953201D0 (no) | 1995-08-15 |
CA2154870C (en) | 1998-10-27 |
CA2154870A1 (en) | 1994-09-01 |
HUT72736A (en) | 1996-05-28 |
EP0684951B1 (en) | 1997-05-07 |
NO953201L (no) | 1995-08-15 |
ES2104358T3 (es) | 1997-10-01 |
EP0611769A1 (en) | 1994-08-24 |
WO1994019356A1 (en) | 1994-09-01 |
JPH08507059A (ja) | 1996-07-30 |
NZ262247A (en) | 1996-01-26 |
GR3024151T3 (en) | 1997-10-31 |
JP3516955B2 (ja) | 2004-04-05 |
NO305517B1 (no) | 1999-06-14 |
ZA94925B (en) | 1994-08-25 |
DK0684951T3 (da) | 1997-05-26 |
DE69403068D1 (en) | 1997-06-12 |
KR100336547B1 (ko) | 2002-11-02 |
FI953851A0 (fi) | 1995-08-15 |
AU672885B2 (en) | 1996-10-17 |
FI953851A (fi) | 1995-08-15 |
FI111461B (fi) | 2003-07-31 |
DE69403068T2 (de) | 1997-12-11 |
EP0684951A1 (en) | 1995-12-06 |
CN1043575C (zh) | 1999-06-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR960701068A (ko) | 실릴화 아세틸콜린에스테라제 억제제(Silylated acetylcholinesterase inhibitors) | |
US4302465B1 (ko) | ||
DK116480A (da) | Fremgangsmaade til fremstilling af substituerede chromoner | |
KR840001952A (ko) | N-(4-(3-아미노프로필) 아미노부틸)-2-(ω)-과니디노-지방산-아미도)-2-치환된-에탄아미드 이들의 염 및 이들의 제조방법 | |
BR8201589A (pt) | Composto,composicao farmaceutica,processo para tratar e/ou evitar a hipertensao,insuficiencia cardiaca congestiva,arritmia,enxaqueca pertubacoes vasospasticas e asma num mamifero e processo para a preparacao de tal composto | |
KR910000757A (ko) | 아세틸콜린에스테라제 억제제인 실릴화 방향족 플루오르화케톤 | |
KR850002459A (ko) | 디히드록시벤즈아미드 유도체 및 그 제조방법 | |
KR840004746A (ko) | 2-옥소-1-아제티딘술폰산 유도체의 제조방법 | |
KR860001048A (ko) | 플루오로알릴아민 유도체의 제조방법 | |
ATE124035T1 (de) | Substituierte 3,4-dihydronaphthaline, diese verbindungen enthaltende arzneimittel und verfahren zur herstellung dieser verbindungen. | |
FI103887B (fi) | Menetelmä terapeuttisesti käyttökelpoisten imidatsolyylimetyyli-pyridiinien valmistamiseksi | |
KR880007490A (ko) | 치환된 아미노프로피온아미드, 이의 제조방법, 이를 함유하는 약제, 이의 용도 및 이의 제조시에 생성된 중간체 | |
FI974435A (fi) | Menetelmä 2,4-diklooripyridiinien muuttamiseksi 2-aryylioksi-4-klooripyridiineiksi | |
ES459186A1 (es) | Un procedimiento para la preparacion de un compuesto de aci-do poliprenilcarboxilico. | |
ATE215934T1 (de) | Neue histidinderivate, verfahren zu ihrer herstellung und ihre verwendung als mittel gegen freie radikale | |
ATE8257T1 (de) | Verfahren zur herstellung von 4-chinolinonen. | |
ATE11912T1 (de) | ((indol-3-yl)-3-amino-2-propionyloxy)-2essigs|urederivate, verfahren zu ihrer herstellung und heilmittel, die sie enthalten. | |
KR850003382A (ko) | 디아릴인단-1,3-디온의 제조방법 | |
KR890005136A (ko) | 아제티디논 n-포스포노메틸 에스테르 | |
ATE29251T1 (de) | Aminopyridincarbonsaeure-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
ES453997A1 (es) | Procedimiento para la preparacion de acetatos de eteraminas secundarias. | |
SE7905025L (sv) | Tereftalsyramonoamidderivat, forfarande for framstellning derav och antiallergiskt medel | |
GB1545077A (en) | Process for purifying water using bis-isothiouronium salts | |
KR840002411A (ko) | 3"'-데히드로카데놀리드 트리디기톡소시드의 옥심의 제조방법 | |
KR920006352A (ko) | 1-카바세팔로스포린에 대한 중간체 및 그의 제조방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
AMND | Amendment | ||
E902 | Notification of reason for refusal | ||
AMND | Amendment | ||
E601 | Decision to refuse application | ||
AMND | Amendment | ||
J201 | Request for trial against refusal decision | ||
B701 | Decision to grant | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20120423 Year of fee payment: 11 |
|
LAPS | Lapse due to unpaid annual fee |